• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤的NKT细胞免疫疗法进展

Advances in NKT cell Immunotherapy for Glioblastoma.

作者信息

Pyaram Kalyani, Yadav Viveka Nand

机构信息

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, USA.

Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, USA.

出版信息

J Cancer Sci Ther. 2018;10(6). doi: 10.4172/1948-5956.1000533. Epub 2018 Jun 18.

DOI:10.4172/1948-5956.1000533
PMID:30147849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6108592/
Abstract

Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR - Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11.

摘要

I型或不变自然杀伤T细胞属于先天T细胞的一个独特谱系,它们分别表达T淋巴细胞和NK细胞的标志物,即T细胞受体(TCR)和NK1.1(CD161C)。因此,除了像NK细胞那样直接杀伤靶细胞外,它们还产生大量调节适应性免疫反应的细胞因子。与携带传统αβ TCR的传统T细胞不同,NKT细胞表达半不变TCR——在小鼠中为Vα14-Jα18,与Vβ8、Vβ7和Vβ2偶联。在人类中,不变TCR由Vα24-Jα18组成,与Vβ11偶联。

相似文献

1
Advances in NKT cell Immunotherapy for Glioblastoma.胶质母细胞瘤的NKT细胞免疫疗法进展
J Cancer Sci Ther. 2018;10(6). doi: 10.4172/1948-5956.1000533. Epub 2018 Jun 18.
2
NKT cell responses to glycolipid activation.NKT细胞对糖脂激活的反应。
Methods Mol Biol. 2010;626:149-67. doi: 10.1007/978-1-60761-585-9_11.
3
Antigen Specificity of Type I NKT Cells Is Governed by TCR β-Chain Diversity.I型自然杀伤T细胞的抗原特异性由TCRβ链多样性决定。
J Immunol. 2015 Nov 15;195(10):4604-14. doi: 10.4049/jimmunol.1501222. Epub 2015 Sep 30.
4
Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver.小鼠肝脏中NK1.1 + T细胞受体α/β +细胞发育对Vβ的严格要求。
J Exp Med. 1996 Mar 1;183(3):1277-82. doi: 10.1084/jem.183.3.1277.
5
CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.CD8 + T细胞在体外和体内受到刺激后会迅速获得NK1.1和NK细胞相关分子。
J Immunol. 2000 Oct 1;165(7):3673-9. doi: 10.4049/jimmunol.165.7.3673.
6
Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands.前沿:TCR Vβ结构域对内源性配体选择半不变自然杀伤T细胞的影响
J Immunol. 2006 Feb 15;176(4):2064-8. doi: 10.4049/jimmunol.176.4.2064.
7
Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.由α-半乳糖神经酰胺(KRN7000)激活的人类恒定Vα24 +自然杀伤T细胞通过不同于T细胞和自然杀伤细胞的机制具有细胞毒性抗肿瘤活性。
Immunology. 2000 Feb;99(2):229-34. doi: 10.1046/j.1365-2567.2000.00952.x.
8
Natural killer T cell-mediated immunotherapy for malignant diseases.自然杀伤T细胞介导的恶性疾病免疫疗法。
Front Biosci (Schol Ed). 2009 Jun 1;1(1):108-16. doi: 10.2741/s10.
9
Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.人CD1d在转基因小鼠中的靶向表达揭示了胸腺细胞和胸腺抗原呈递细胞在Vα14i自然杀伤T细胞阳性和阴性选择中的独立作用。
J Immunol. 2005 Dec 1;175(11):7303-10. doi: 10.4049/jimmunol.175.11.7303.
10
CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.胸腺中CD161(NK1)-CD44lowCD4 + CD8 - T细胞中白细胞介素-4基因快速诱导性的CD1d非依赖性发育获得与互补决定区3多样且偏向性的Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T细胞受体使用情况相关。
J Immunol. 2005 Nov 15;175(10):6537-50. doi: 10.4049/jimmunol.175.10.6537.

引用本文的文献

1
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy.嵌合抗原受体自然杀伤T细胞疗法:癌症免疫疗法的一种新的有前景的模式。
Cancer Cell Int. 2023 May 8;23(1):86. doi: 10.1186/s12935-023-02923-9.
2
Development and Characterization of an HCMV Multi-Antigen Therapeutic Vaccine for Glioblastoma Using the UNITE Platform.利用 UNITE 平台开发用于胶质母细胞瘤的人巨细胞病毒多抗原治疗性疫苗并进行表征。
Front Oncol. 2022 May 16;12:850546. doi: 10.3389/fonc.2022.850546. eCollection 2022.
3
MR1 overexpression correlates with poor clinical prognosis in glioma patients.MR1过表达与胶质瘤患者不良临床预后相关。
Neurooncol Adv. 2021 Feb 20;3(1):vdab034. doi: 10.1093/noajnl/vdab034. eCollection 2021 Jan-Dec.
4
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.神经肿瘤学中的过继免疫疗法:分类、最新进展和转化挑战。
Acta Biomed. 2020 Jun 30;91(7-S):18-31. doi: 10.23750/abm.v91i7-S.9952.
5
NKT Cells in Neurological Diseases.神经疾病中的自然杀伤T细胞
Front Cell Neurosci. 2019 May 29;13:245. doi: 10.3389/fncel.2019.00245. eCollection 2019.

本文引用的文献

1
Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy.利用不变自然杀伤 T 细胞进行癌症免疫治疗的新方法。
Front Immunol. 2018 Mar 2;9:384. doi: 10.3389/fimmu.2018.00384. eCollection 2018.
2
The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.自然杀伤 T 细胞在自身免疫和传染病中的双面作用。
Int J Mol Sci. 2018 Feb 1;19(2):440. doi: 10.3390/ijms19020440.
3
Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.自然杀伤性T细胞:生态-进化-发育生物学视角
Front Immunol. 2017 Dec 22;8:1858. doi: 10.3389/fimmu.2017.01858. eCollection 2017.
4
Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger.活性氧通过早幼粒细胞白血病锌指蛋白调节NKT细胞的炎症功能。
J Immunol. 2017 Nov 15;199(10):3478-3487. doi: 10.4049/jimmunol.1700567. Epub 2017 Oct 11.
5
Natural Killer T Cells in Cancer Immunotherapy.癌症免疫疗法中的自然杀伤T细胞。
Front Immunol. 2017 Sep 22;8:1178. doi: 10.3389/fimmu.2017.01178. eCollection 2017.
6
Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity.介导长期记忆反应和强大抗肿瘤活性的自然杀伤T细胞靶向免疫疗法。
Front Immunol. 2017 Sep 25;8:1206. doi: 10.3389/fimmu.2017.01206. eCollection 2017.
7
Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma.基于树突状细胞的免疫疗法共递送肿瘤来源的外泌体与α-半乳糖神经酰胺用于胶质母细胞瘤。
Cancer Lett. 2017 Dec 28;411:182-190. doi: 10.1016/j.canlet.2017.09.022. Epub 2017 Sep 23.
8
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.将自然杀伤T细胞(NKT)激动剂α-半乳糖神经酰胺与肿瘤抗原共同递送至交叉呈递树突状细胞可打破对自身抗原的耐受性并促进抗肿瘤反应。
Oncoimmunology. 2017 Aug 18;6(9):e1339855. doi: 10.1080/2162402X.2017.1339855. eCollection 2017.
9
Temporal regulation of Wnt/β-catenin signaling is important for invariant NKT cell development and terminal maturation.Wnt/β-连环蛋白信号通路的时间调控对于恒定自然杀伤T细胞的发育和终末成熟至关重要。
Mol Immunol. 2017 May;85:47-56. doi: 10.1016/j.molimm.2017.01.025. Epub 2017 Feb 14.
10
Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.2010年美国原发性恶性脑肿瘤登记数据的完整患病率与其他常见癌症的比较。
Neuro Oncol. 2017 May 1;19(5):726-735. doi: 10.1093/neuonc/now252.